Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers

Yale receives renewed lung cancer SPORE grant from NCI

Yale Cancer Center’s Specialized Program of Research Excellence in Lung Cancer was awarded a renewal grant from NCI for year 11 of the program.

September 19, 2025

Vol.51 No.34

In Brief

City of Hope expands clinical trial access across U.S. with new national model

City of Hope launched a national clinical trials model to expand access to emerging life-saving cancer treatments to more patients across the country.

September 19, 2025

Vol.51 No.34

In Brief

The Fund for Science and Technology awards $500 million to four grantees in Seattle for immunotherapy research, climate science

The Fund for Science and Technology announced an inaugural suite of grants and its plan to fund at least $500 million over the next four years to support transformational science and technology for people and the planet.

September 19, 2025

Vol.51 No.34

Clinical Roundup

Libtayo + chemo shows significant improvement in OS for advanced NSCLC, phase III EMPOWER-Lung 3 trial shows

Libtayo (cemiplimab) plus chemotherapy demonstrates a more than double five-year overall survival rate of 19.4%, compared to 8.8% with chemotherapy alone, according to late-breaking data from exploratory analyses at World Conference on Lung Cancer.

September 19, 2025

Vol.51 No.34

Breaking barriers in lung cancer research

The fight against lung cancer is evolving, with groundbreaking research shedding light on the intricate interplay between biology, environment, and health disparities.

September 12, 2025

Vol.51 No.33

By Loretta Erhunmwunsee

Obituary

Bonnie Addario, lung cancer survivor and advocate, dies at 77

Bonnie J. Addario, a tireless advocate, died Aug. 25, leaving behind a legacy of love, leadership, and global impact. Bonnie was first and foremost devoted to her family—her husband of over 40 years, Tony; her children Danielle, Jared, and Andrea; her nine grandchildren; and five great-grandchildren. To all of them, she was the heart of...

September 12, 2025

Vol.51 No.33

By Neptune Society

Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers

YOU MAY BE INTERESTED IN

Yale receives renewed lung cancer SPORE grant from NCI

City of Hope expands clinical trial access across U.S. with new national model

The Fund for Science and Technology awards $500 million to four grantees in Seattle for immunotherapy research, climate science

Libtayo + chemo shows significant improvement in OS for advanced NSCLC, phase III EMPOWER-Lung 3 trial shows

Breaking barriers in lung cancer research

Bonnie Addario, lung cancer survivor and advocate, dies at 77

Renew today!

Subscriber content

Never miss an issue!

Login